N
Naoto T. Ueno
Researcher at University of Texas MD Anderson Cancer Center
Publications - 390
Citations - 13778
Naoto T. Ueno is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Breast cancer & Inflammatory breast cancer. The author has an hindex of 59, co-authored 389 publications receiving 11623 citations. Previous affiliations of Naoto T. Ueno include University of Texas Health Science Center at Houston & The Breast Cancer Research Foundation.
Papers
More filters
Journal ArticleDOI
Factors Associated with Pathological Node Negativity in Inflammatory Breast Cancer: Are There Patients Who May be Candidates for a De-Escalation of Axillary Surgery?
Lauren M. Postlewait,Mediget Teshome,Sarah M. DeSnyder,Bora Lim,Henry Mark Kuerer,Isabelle Bedrosian,Wendy A. Woodward,Naoto T. Ueno,Anthony Lucci +8 more
TL;DR: The frequency and factors associated with pathological node-negativity (ypN0) in IBC were described and one-third of patients with IBC who received NAC and MRM had pathologically negative nodes.
Journal ArticleDOI
Effects of CDK4/6 Inhibition in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Cells with Acquired Resistance to Paclitaxel.
TL;DR: The results suggest that patients who have HR-positive/HER2-negative residual disease after taxane-based neoadjuvant chemotherapy may still benefit from palbociclib in combination with other regimens, such as endocrine therapies, for adjuvant therapy.
BookDOI
Inflammatory breast cancer: An update
TL;DR: Book of inflammatory breast cancer an update, as an amazing reference becomes what you need to get, as a source that may involve the facts, opinion, literature, religion, and many others are the great friends to join with.
Journal ArticleDOI
The Role of Mastectomy in De Novo Stage IV Inflammatory Breast Cancer.
Natalia S. Partain,Lauren M. Postlewait,Mediget Teshome,Kelly Rosso,Carolyn S. Hall,Juhee Song,Salyna Meas,Sarah M. DeSnyder,Bora Lim,Vicente Valero,Wendy A. Woodward,Naoto T. Ueno,Henry Mark Kuerer,Anthony Lucci +13 more
TL;DR: The role of modified radical mastectomy (MRM) in patients with de novo stage IV inflammatory breast cancer (IBC) remains controversial. as discussed by the authors evaluated the impact of MRM on outcomes in this population.
Posted ContentDOI
A phase II study of talimogene laherparepvec for patients with inoperable locoregional recurrence of breast cancer.
Megumi Kai,Angela N. Marx,Diane D. Liu,Yu Shen,Hui Gao,James M. Reuben,Gary J. Whitman,Savitri Krishnamurthy,Merrick I. Ross,Jennifer K. Litton,Bora Lim,Bora Lim,Nuhad K. Ibrahim,Takahiro Kogawa,Naoto T. Ueno +14 more
TL;DR: None of the patients was able to complete the planned 10 cycles due to the disease progression, and future studies could examine whether combining intratumoral T-VEC with concurrent systemic therapy produces better outcomes.